DE60121735D1 - Neues menschliches ulip/crmp protein und seine verwendung zur diagnose zur behandlung von krebs und von neurologischen paraneoplastischen syndromen - Google Patents

Neues menschliches ulip/crmp protein und seine verwendung zur diagnose zur behandlung von krebs und von neurologischen paraneoplastischen syndromen

Info

Publication number
DE60121735D1
DE60121735D1 DE60121735A DE60121735A DE60121735D1 DE 60121735 D1 DE60121735 D1 DE 60121735D1 DE 60121735 A DE60121735 A DE 60121735A DE 60121735 A DE60121735 A DE 60121735A DE 60121735 D1 DE60121735 D1 DE 60121735D1
Authority
DE
Germany
Prior art keywords
diagnosis
cancer
treatment
new human
paraneoplastic syndrome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60121735A
Other languages
English (en)
Other versions
DE60121735T4 (de
DE60121735T2 (de
Inventor
Michele Aguera
Jean-Christophe Antoine
Marie-Francoise Belin
Jerome Honnorat
Veronique Rogemont
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26212215&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60121735(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from FR0002566A external-priority patent/FR2805540B1/fr
Priority claimed from FR0005005A external-priority patent/FR2807757B1/fr
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Application granted granted Critical
Publication of DE60121735D1 publication Critical patent/DE60121735D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
DE60121735A 2000-02-29 2001-02-28 Neues menschliches ulip/crmp protein und seine verwendung zur diagnose zur behandlung von krebs und von neurologischen paraneoplastischen syndromen Expired - Lifetime DE60121735D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0002566A FR2805540B1 (fr) 2000-02-29 2000-02-29 Nouvelle proteine ulip humaine et son utilisation dans le diagnostic et la therapie des cancers et des syndromes neurologiques paraneoplasiques
FR0005005A FR2807757B1 (fr) 2000-04-18 2000-04-18 Nouvelle proteine ulip/crmp humaine et son utilisation dans le diagnostic et la therapie des cancers et des syndromes neurologiques et paraneoplastiques
PCT/FR2001/000589 WO2001064737A1 (fr) 2000-02-29 2001-02-28 Nouvelle proteine ulip/crmp humaine et son utilisation dans le diagnostic et la therapie des cancers et des syndromes neurologiques paraneoplasiques

Publications (1)

Publication Number Publication Date
DE60121735D1 true DE60121735D1 (de) 2006-09-07

Family

ID=26212215

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60121735T Expired - Lifetime DE60121735T4 (de) 2000-02-29 2001-02-28 Neues menschliches ULIP/CRMP-Protein und seine Verwendung bei der Diagnose und Behandlung von Krebsen und paraneoplastischen neurologischen Syndromen
DE60121735A Expired - Lifetime DE60121735D1 (de) 2000-02-29 2001-02-28 Neues menschliches ulip/crmp protein und seine verwendung zur diagnose zur behandlung von krebs und von neurologischen paraneoplastischen syndromen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE60121735T Expired - Lifetime DE60121735T4 (de) 2000-02-29 2001-02-28 Neues menschliches ULIP/CRMP-Protein und seine Verwendung bei der Diagnose und Behandlung von Krebsen und paraneoplastischen neurologischen Syndromen

Country Status (8)

Country Link
US (4) US7329499B2 (de)
EP (1) EP1263784B1 (de)
JP (1) JP4990459B2 (de)
AT (1) ATE334145T1 (de)
CA (1) CA2401438C (de)
DE (2) DE60121735T4 (de)
ES (1) ES2269353T3 (de)
WO (1) WO2001064737A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002002620A2 (en) * 2000-06-29 2002-01-10 Mayo Foundation For Medical Education And Research Crmp-5 (collapsin response-mediator protein) encoding nucleic acid, polypeptide and uses thereof
DE102009033281B4 (de) 2009-07-15 2018-12-13 Euroimmun Medizinische Labordiagnostika Ag Verfahren zur Detektion von Autoantikörpern bei paraneoplastischen neurologischen Syndromen
WO2020154654A1 (en) * 2019-01-25 2020-07-30 Mayo Foundation For Medical Education And Research Assessing and treating germ cell tumors and paraneoplastic autoimmunity
CN114375396A (zh) 2019-09-13 2022-04-19 欧蒙医学实验诊断股份公司 改进的nmda受体自身抗体检测
CN112270684B (zh) * 2020-12-25 2021-04-06 宁波兰茜生物科技有限公司 一种显微图像免疫组化虚拟多重标记及分析方法及系统

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2759701B1 (fr) * 1997-02-19 1999-06-04 Inst Nat Sante Rech Med Utilisation des proteines ulip dans le diagnostic et la therapie des cancers et des syndromes neurologiques paraneoplasiques
US20050175607A1 (en) * 2000-02-28 2005-08-11 Tang Y T. Novel nucleic acids and polypeptides
AU2001241511A1 (en) * 2000-02-28 2001-09-12 Hyseq, Inc. Novel nucleic acids and polypeptides

Also Published As

Publication number Publication date
JP4990459B2 (ja) 2012-08-01
CA2401438C (fr) 2011-11-29
JP2003525059A (ja) 2003-08-26
ATE334145T1 (de) 2006-08-15
US20030176336A1 (en) 2003-09-18
US20130243755A1 (en) 2013-09-19
US20190119339A1 (en) 2019-04-25
ES2269353T3 (es) 2007-04-01
CA2401438A1 (fr) 2001-09-07
DE60121735T4 (de) 2010-07-08
US8377645B2 (en) 2013-02-19
EP1263784B1 (de) 2006-07-26
EP1263784A1 (de) 2002-12-11
US20080226636A1 (en) 2008-09-18
DE60121735T2 (de) 2007-08-30
WO2001064737A1 (fr) 2001-09-07
US7329499B2 (en) 2008-02-12
US10087220B2 (en) 2018-10-02

Similar Documents

Publication Publication Date Title
ATE283289T1 (de) Monoklonale antikörper, antigene sowie diagnose und therapie von bösartigen krankheiten
CY1109837T1 (el) Διαγνωστικο και θεραπευτικο επιτοπιο
ATE403001T1 (de) Antigenbindungsfragmente die spezifisch krebszellen nachweisen, nukleotide die für diese fragmente kodieren, und deren verwendung zur vorbeugung und zum nachweis von krebs
CY1105446T1 (el) Διαγνωση και θepαπεια διαταραχων που συνδεονται με aur1 και aur2
DK0458878T3 (da) Nyt monoklonalt antistof mod et nyt antigen, der er associeret med humane tumorer
WO2001059064A3 (en) Nucleic acids, proteins, and antibodies
DE3686304D1 (de) Typenspezifische papillomavirus-dns-sequenzen und peptide.
DE60136099D1 (de) Zusammensetzungen zur behandlung und diagnose von eierstockkrebs
ATE461938T1 (de) Mit entzündlichen darmerkrankungen (ibd) assoziierte mikrobielle antigene und verfahren derer anwendung
ATE182180T1 (de) Lamanin-ketten: diagnostische und therapeutische verwendung
DE60028544D1 (de) Prostata-spezifische gene zur diagnose, prognose und behandlung von prostata-krebs
DE69735020D1 (de) Verfahren zur Diagnose von Prostatakrebs
ATE547523T1 (de) Vegfr-varianten und deren verwendung bei der diagnose und behandlung von mit schwangerschaft assoziierten medizinischen leiden
DK1536006T3 (da) Cancerantigener og anvendelse deraf
DE60121735D1 (de) Neues menschliches ulip/crmp protein und seine verwendung zur diagnose zur behandlung von krebs und von neurologischen paraneoplastischen syndromen
ATE463508T1 (de) Reagentien und verfahren zur erkennung von erkrankungen der brust
DE60026733D1 (de) Histone-deacetylase-8 proteine, nukleinsäuren und methoden zur verwendung
ATE432287T1 (de) Peptidfragmente mit den zelltod verhindernder aktivität
ATE517629T1 (de) Verwendung eines proteins der crmp familie zur behandlung von krankheiten des immunsystems
ATE265533T1 (de) Saeugetierchemokine
EP0834568A3 (de) Speichel-bindendes Protein von Streptococcus pneumoniae
JP2007530420A5 (de)
PT629238E (pt) Autotaxina: proteina estimuladora da motilidade util no diagnostico e tarapia do cancro
NO993653D0 (no) Fremgangsmåte for diagnose, prognose og behandling av glaukom og relaterte sykdommer
DE69939379D1 (de) Hemmstoff zur diagnose und behandlung von haemophilia a patienten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8310 Action for declaration of annulment
8328 Change in the person/name/address of the agent

Representative=s name: VOSSIUS & PARTNER, 81675 MUENCHEN

8313 Request for invalidation rejected/withdrawn